Pfizer board authorizes $11 billion share repurchase

Oct 23 (Reuters) - Pfizer Inc on Thursday said its board of directors has authorized an $11 billion share repurchase program to be utilized over time.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.